{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T21:28:44Z","timestamp":1794518924385,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010449","name":"Nationales Centrum f\u00fcr Tumorerkrankungen Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.esmoop.2026.106082","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:21:53Z","timestamp":1778275313000},"page":"106082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"11","author":[{"given":"F.","family":"Nichetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5830-3616","authenticated-orcid":false,"given":"P.","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Korell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huellein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uhrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5388-573X","authenticated-orcid":false,"given":"M.","family":"R\u00fcbsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-V.","family":"Teleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2310-9475","authenticated-orcid":false,"given":"M.","family":"Jenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kreutzfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-9306","authenticated-orcid":false,"given":"P.","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Konietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Glimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Heining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-7977","authenticated-orcid":false,"given":"D.","family":"Rieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-101X","authenticated-orcid":false,"given":"C.","family":"Springfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8869-1421","authenticated-orcid":false,"given":"C.E.","family":"Heilig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"H\u00fcbschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-4595","authenticated-orcid":false,"given":"S.","family":"Fr\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmoop.2026.106082_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma \u2013 evolving concepts and therapeutic strategies","volume":"15","author":"Ilyas","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2026.106082_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.esmoop.2026.106082_bib4","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.ejso.2019.04.002","article-title":"Increased multimodality treatment options has improved survival for hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged","volume":"45","author":"Alabraba","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2026.106082_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/0284186X.2019.1590634","article-title":"Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study","volume":"58","author":"Strijker","year":"2019","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","article-title":"Cholangiocarcinoma 2026: status quo, unmet needs and priorities","volume":"23","author":"Banales","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.106082_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106082_bib8","doi-asserted-by":"crossref","first-page":"10156","DOI":"10.1002\/cam4.5719","article-title":"Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma","volume":"12","author":"Silvestri","year":"2023","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106082_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2026.106082_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.106082_bib11","article-title":"Real-world outcomes of molecular tumor board treatment recommendations","volume":"9","author":"Nichetti","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.106082_bib12","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41591-025-03918-x","article-title":"Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial","volume":"31","author":"Marchetti","year":"2025","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.esmoop.2026.106082_bib13","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/2159-8290.CD-21-0126","article-title":"Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers","volume":"11","author":"Horak","year":"2021","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106082_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106082_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70502","article-title":"FOLFOX versus FOLFIRI as second-line chemotherapy in patients with advanced biliary tract cancers: a multicenter, Italian study","volume":"46","author":"Pircher","year":"2026","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41698-024-00788-3","article-title":"Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology","volume":"9","author":"Kerle","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41698-023-00458-w","article-title":"NCT\/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology","volume":"7","author":"Mock","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"Spec No","key":"10.1016\/j.esmoop.2026.106082_bib18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/5.Supplement_1.1489","article-title":"Mismatch repair defects in human carcinogenesis","volume":"5","author":"Eshleman","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.esmoop.2026.106082_bib19","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"issue":"9","key":"10.1016\/j.esmoop.2026.106082_bib20","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13059-016-1114-x","article-title":"A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence","volume":"17","author":"Canisius","year":"2016","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.106082_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1101\/gr.257246.119","article-title":"Accurate and efficient detection of gene fusions from RNA sequencing data","volume":"31","author":"Uhrig","year":"2021","journal-title":"Genome Res"},{"key":"10.1016\/j.esmoop.2026.106082_bib23","unstructured":"Draw_Fusions.R. Available at https:\/\/github.com\/suhrig\/arriba\/blob\/master\/draw_fusions.R. Accessed January 19, 2022."},{"issue":"suppl 2","key":"10.1016\/j.esmoop.2026.106082_bib24","article-title":"131O A composite biomarker for evaluation of homologous recombination repair deficiency in a pan-cancer cohort","volume":"34","author":"R\u00fcbsam","year":"2023","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106082_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/s41467-018-03843-3","article-title":"Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm","volume":"9","author":"Ding","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41698-025-01231-x","article-title":"Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials","volume":"10","author":"Nichetti","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106082_bib29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.esmoop.2026.106082_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-2-10","article-title":"Worldwide trends in mortality from biliary tract malignancies","volume":"2","author":"Patel","year":"2002","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2026.106082_bib31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.esmoop.2026.106082_bib32","article-title":"Prognostic role of MTAP loss in cholangiocarcinoma","volume":"9","author":"Lyon","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.esmoop.2026.106082_bib33","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.esmoop.2026.106082_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102649","article-title":"Molecular profiling in cholangiocarcinoma: a practical guide to next-generation sequencing","volume":"122","author":"Stenzinger","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106082_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae340","article-title":"Precision medicine: an intrahepatic cholangiocarcinoma with a novel RBPMS-MET fusion sensitive to crizotinib","volume":"30","author":"Wan","year":"2025","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106082_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/03008916251345409","article-title":"Validating HER2 copy number variation assessment by NGS: a comparative analysis with immunohistochemistry and in situ hybridization","volume":"111","author":"Lorenzini","year":"2025","journal-title":"Tumori"},{"key":"10.1016\/j.esmoop.2026.106082_bib37","article-title":"Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: current advancements and future perspectives","volume":"199","author":"Haaft","year":"2024","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106082_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.esmoop.2026.106082_bib39","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/cancers15113047","article-title":"Third-line palliative systemic therapy for advanced biliary tract cancer: multicentre review of patterns of care and outcomes","volume":"15","author":"Gray","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.esmoop.2026.106082_bib40","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4161\/cc.8.19.9455","article-title":"The protein tyrosine phosphatase receptor D, a broadly inactivated tumor suppressor regulating STAT function","volume":"8","author":"Chan","year":"2009","journal-title":"Cell Cycle"},{"issue":"19","key":"10.1016\/j.esmoop.2026.106082_bib41","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1158\/0008-5472.CAN-08-0904","article-title":"Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma","volume":"68","author":"Cheung","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106082_bib42","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cellsig.2007.12.024","article-title":"PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin\/E-cadherin complexes in cancer cells","volume":"20","author":"Novellino","year":"2008","journal-title":"Cell Signal"},{"issue":"5674","key":"10.1016\/j.esmoop.2026.106082_bib43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1096096","article-title":"Mutational analysis of the tyrosine phosphatome in colorectal cancers","volume":"304","author":"Wang","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.esmoop.2026.106082_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2017.10.013","article-title":"Precision medicine for patients with advanced biliary tract cancers: an effective strategy within the prospective MOSCATO-01 trial","volume":"87","author":"Verlingue","year":"2017","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106082_bib45","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/1078-0432.CCR-21-2384","article-title":"ESMO Scale for Clinical Actionability of Molecular Targets driving targeted treatment in patients with cholangiocarcinoma","volume":"28","author":"Verdaguer","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:46:08Z","timestamp":1794516368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2059702926000244"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.106082","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.106082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"106082"}}